Lesinurad (brand name Zurampic) is a urate transporter inhibitor for treating high blood uric acid levels associated with gout. It is recommended only...
11 KB (896 words) - 19:22, 20 December 2023
Lesinurad/allopurinol (trade name Duzallo) is a fixed-dose combination drug for the treatment of gout. It contains 200 mg of lesinurad and 300 mg of allopurinol...
3 KB (175 words) - 19:22, 20 December 2023
rate of side effects and many people develop resistance to it. Using lesinurad 400 mg plus febuxostat is more beneficial for tophi resolution than lesinural...
83 KB (8,329 words) - 00:15, 19 October 2024
Milurit, Alloril, Progout, Ürikoliz, Zyloprim, Zyloric, Zyrik, and Aluron. Lesinurad/allopurinol, a fixed-dose combination drug "Allopurinol Use During Pregnancy"...
31 KB (2,798 words) - 23:42, 18 October 2024
M04AB02 Sulfinpyrazone M04AB03 Benzbromarone M04AB04 Isobromindione M04AB05 Lesinurad M04AC01 Colchicine M04AC02 Cinchophen M04AC51 Colchicine and probenecid...
860 bytes (197 words) - 03:41, 18 December 2023
[citation needed] Uricosuric agents (benzbromarone, benziodarone, probenecid, lesinurad, sulfinpyrazone, ethebencid, zoxazolamine, and ticrynafen) increase the...
28 KB (3,197 words) - 04:14, 24 October 2024
particularly OCT2. It can affect the pharmacokinetics of other cationic drugs. Lesinurad: This drug inhibits URAT1 (Urate Transporter 1) in the proximal tubule...
6 KB (581 words) - 06:52, 26 October 2024
SLC22A12 has been shown to have a protein-protein interaction with PDZK1. Lesinurad, Ruzinurad, Verinurad, Epaminurad, Lingdolinurad, Xininurad, Puliginurad...
9 KB (1,079 words) - 11:05, 18 July 2024
Biosciences for $1 billion (Net of existing cash) including lead product lesinurad in Phase III development for gout". AstraZeneca. 23 April 2012. Retrieved...
37 KB (4,737 words) - 09:58, 27 March 2024